We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > DBV

News List

DBV CMO leaves as peanut allergy player rejigs team in wake of BLA withdrawal fiercebiotech
January 07, 2019
Lucia Septién-Velez has stepped down (PDF) as chief medical officer of DBV Technologies. The departure of Septién-Velez is part of a wider reshuffle that gives DBV’s management a new look as it seeks to get its BLA back on track.....
DBV pulls peanut allergy filing after FDA faults data details fiercebiotech
December 25, 2018
DBV Technologies has withdrawn the filing for FDA approval of its peanut allergy therapy. The French biotech pulled the BLA after talks with the agency revealed gaps in the manufacturing and quality-control sections of the filing....